Leqembi is approved for Alzheimer’s patients in multiple territories, but questions remain over its cost-effectiveness.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback